Shilpa Medicare shares rose today after the company secured GMP certification from Saudi Arabia's SFDA for its Unit VI ...

Shilpa Medicare's Unit VI facility, located at Dabaspet, Bengaluru, Karnataka, has received SFDA, Saudi Arabia, GMP certification.

Karnataka: Shilpa Medicare has announced that its Unit VI facility, located at Dabaspet, Bengaluru, Karnataka, has received ...

Trump’s tax bill could reshape drug R&D, manufacturing, Medicaid access, clinical trials, and biotech funding, impacting ...

CPHI China has long been recognized as a premier platform for connecting the entire pharmaceutical supply chain, from active ...

Laurus Labs pharma stock jumps 23 per cent in one month on strong CDMO growth, FY25 earnings, and margin expansion.

Laurus Labs shares rose over 2% in Monday's trading, marking three days of gains. In June 2025, the stock has gained 18%, ...

Chandan Taparia, head of technical and derivatives research at Motilal Oswal Financial Services Ltd., has recommended three ...

Despite increased scrutiny, Indian exports to US to maintain growth trajectory, says CareEdge Ratings: Our Bureau, New Delhi Thursday, June 26, 2025, 17:20 Hrs [IST] Even as the I ...

Even as the Indian pharma sector catering to the US market may see further increased scrutiny from the US drug regulator during the year, the sector is expected to maintain its growth trajectory, ...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its wholly-owned subsidiary T-mab has entered into an agreement with Qilu Pharmaceutical for ...